Page last updated: 2024-08-16

trapidil and osteoprotegerin

trapidil has been researched along with osteoprotegerin in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ha, H; Hwang, SJ; Jin, WJ; Kim, HH; Kim, HN; Kim, SD; Lee, JH; Lee, ZH1

Other Studies

1 other study(ies) available for trapidil and osteoprotegerin

ArticleYear
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Biochemical pharmacology, 2013, Sep-15, Volume: 86, Issue:6

    Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Marrow Cells; Bone Resorption; Calcium; Coculture Techniques; Gene Expression Regulation; Interleukin-1; Male; Mice; Mice, Inbred ICR; NFATC Transcription Factors; Osteoclasts; Osteoprotegerin; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-pim-1; RANK Ligand; Signal Transduction; Trapidil

2013